Daylight Savings linked to increased medical errors

Article

Human errors including medications, administering either the wrong dose or the wrong drug, seem to increase by 18 percent

Although the U.S. is about to “fall back” with the end of 2020’s Daylight Savings Time (DST), research has showed that the start of DST may be behind medical errors.

Medical errors are more likely to occur in the days following the “spring ahead” DST switch, an observational study found.1

As part of the Mayo Clinic Health System, healthcare workers are encouraged to voluntarily report patient safety-related incidents caused by defective systems, equipment, or human error. The data collected from this record of reports was examined for errors in the 7 days preceding and following the spring and fall time changes, over a period of 8 years.

By and large, there were no substantial differences in errors reported in the weeks before and after DST. However, when researchers constrained their analysis to only human errors, they found a statistically significant increase of 18.7 percent human errors when an hour was lost in the spring. The majority of errors occurring during this time involved medications, administering either the wrong dose or the wrong drug.

When it came to the fall switch back to standard time, when an hour is gained, there were no significant differences in human errors in the weeks preceding and following DST.

Delayed start times and other contingency measures are suggested to help mitigate the increased risk of errors in the spring.

Do you plan to hand out candy to trick or treaters this Halloween, during the pandemic?

Reference

1. Kolla BP, Coombes BJ, Morgenthaler TI, Mansukhani MP. Increased Patient Safety-Related Incidents Following the Transition into Daylight Savings Time. J Gen Intern Med. 2020. DOI: s11606-020-06090-9.

Recent Videos
David Geffen, OD, FAAO, gave a poster presentation titled "Revolutionizing Comfort: Unveiling the Potential of Perfluorohexyloctane Eyedrops for Contact Lens Wearers" at this year's Academy meeting.
Jessica Steen, OD, FAAO, Dipl-ABO, discussed ophthalmic considerations for patients undergoing treatment with antibody drug conjugates for gynecologic cancers at this year's conference.
A. Paul Chous, MA, OD, FAAO, details a presentation on this year's updates on diabetes given at this year's Academy meeting
Sherrol Reynolds, OD, FAAO, said that multimodel imaging has been a game changer in assessing the choroidal function and structural changes in various disease conditions.
Susan Gromacki, OD, FAAO, FSLS, provides key takeaways from this year's American Academy of Optometry symposium genetics and the cornea.
Roya Attar gives an overview of her presentation, "Decoding the Retina: The Value of Genetic Testing In Inherited Disorders," presented with Mohammad Rafieetary, OD, FAAO, FORS, ABO, ABCMO.
Ian Ben Gaddie, OD, FAAO, outlines key findings from a recent study evaluating lotilaner in patients with Demodex blepharitis and meibomian gland dysfunction.
Clark Chang, OD, MSA, MSc, FAAO, discussed the complexities of diagnosing keratoconus in his Rapid Fire presentation given at the American Academy of Optometry 2024 meeting.
Mohammad Rafieetary, OD, FAAO, FORS, Dipl ABO, ABCMO, details the ease of genetic testing when diagnosing patients or reassessing a patient's diagnosis.
Gromacki, OD, FAAO, FSLS, emphasizes that corneal GP lenses remain an important part of a contact lens specialist's armamentarium
© 2024 MJH Life Sciences

All rights reserved.